Results 171 to 180 of about 9,401 (207)
More Than Five Years of Sustained Remission With Mepolizumab in Adolescent-Onset Eosinophilic Granulomatosis With Polyangiitis: A Case Report. [PDF]
Araya T +4 more
europepmc +1 more source
Clinical Images: Löffler endocarditis: a rare cardiac manifestation of eosinophilic granulomatosis with polyangiitis. [PDF]
Scangarello FA, Ahmed AN, Alduraibi FK.
europepmc +1 more source
Eosinophilic granulomatosis with polyangiitis related giant coronary aneurysm leading to acute myocardial infarction: a case report. [PDF]
Okamoto K +4 more
europepmc +1 more source
Orbital Presentation of Eosinophilic Granulomatosis with Polyangiitis: An Interventional Case Report and Literature Review. [PDF]
Barut Selver O +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Targeting Eosinophils in Eosinophilic Granulomatosis with Polyangiitis
New England Journal of Medicine, 2017Eosinophilic granulomatosis with polyangiitis, first described in the early 1950s by Dr. Jacob Churg and Dr. Lotte Strauss (hence the original name, the Churg–Strauss syndrome), is a rare condition that can affect many organ systems, most commonly the lung, with the majority of patients presenting with asthma symptoms, occasionally complicated by the ...
Djukanović, Ratko, O'Byrne, Paul
openaire +4 more sources
Eosinophilic granulomatosis with polyangiitis
Medicina Clínica (English Edition), 2023Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic vasculitis characterized by the presence of asthma associated with eosinophilia, eosinophilic infiltration of different organs, and vasculitis of small and medium-sized vessels. Although classified as anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, it occurs in less ...
Yann Nguyen, Loïc Guillevin
+7 more sources
Biologics for eosinophilic granulomatosis with polyangiitis
Current Opinion in Allergy & Clinical Immunology, 2022Purpose of review The link between severe asthma and eosinophilic granulomatosis with polyangiitis (EGPA) in terms of pathophysiological background, clinical manifestations and disease evolution has leaded to investigate the relevance of anti T2 monoclonal antibodies licensed for severe asthma patients as a treatment option for
Caminati, Marco +3 more
openaire +4 more sources

